OVARIAN CANCER RECURRENT
Clinical trials for OVARIAN CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CANCER RECURRENT trials appear
Sign up with your email to follow new studies for OVARIAN CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo for Hard-to-Treat ovarian cancer never got off the ground
Disease control TerminatedThis study was designed to test whether a new drug called M4344, combined with the PARP inhibitor niraparib, could be safe and effective for women with recurrent ovarian cancer that had stopped responding to PARP inhibitors. The plan was to enroll women with advanced ovarian, pri…
Matched conditions: OVARIAN CANCER RECURRENT
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New combo therapy targets recurrent ovarian cancer
Disease control OngoingThis study tests a new treatment for women whose ovarian cancer has come back. It combines chemotherapy and immunotherapy given directly into the abdomen with a drug given through a vein. The goal is to see if this approach can shrink or eliminate tumors. The study involves 24 pa…
Matched conditions: OVARIAN CANCER RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Robert Edwards • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC